Altisource Portfolio Solutions is a marketplace and transaction solutions provider for the real estate, mortgage and consumer debt industries. Co. has three reportable segments: mortgage services, which provides asset management services, origination services, insurance services, property valuation services, and default management services; financial services, which provides collection services primarily to debt originators and servicers and customer relationship management services primarily to the utility, insurance and hotel industries; and technology services, which provides software and data analytics solutions and information technology infrastructure management services.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

Patriot National Bancorp is a bank holding company. Through its subsidiary, Patriot Bank, N.A (the Bank), the company provides commercial real estate loans, commercial business loans, and a variety of consumer loans. Consumer and commercial deposit accounts provided include: checking, interest-bearing negotiable order of withdrawal, money market, time certificates of deposit, savings, Certificate of Deposit Account Registry Service, Individual Retirement Accounts, and Health Savings Accounts. Other services provided by the Bank include Automated Clearing House transfers, lockbox, internet banking, bill paying, remote deposit capture, debit cards, money orders, and automatic teller machines.

PBF Energy is a holding company. Through its subsidiaries, the company is engaged as an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants and other petroleum products in the U.S. The company operates in two business segments: refining, which the company produces a variety of products at each of its refineries such as gasoline, ultra-low-sulfur diesel, heating oil, jet fuel, lubricants, petrochemicals and asphalt; and logistics, which through its PBF Logistics LP subsidiary, the company owns or leases, operates, develops and acquires crude oil and refined petroleum products terminals, pipelines, storage facilities and similar logistics assets.

Savara is an orphan lung disease company. The company's drug development pipeline comprises Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor in development for pulmonary alveolar proteinosis and in development for nontuberculous mycobacterial lung infection; and AeroVanc, an inhaled vancomycin for treatment of persistent methicillin-resistant Staphylococcus aureus lung infection in individuals living with cystic fibrosis.